Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 by admin June 4, 2025 June 4, 2025 Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com previous post 5 Biggest Blockchain ETFs in 2025 next post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case You may also like Blackstone Completes Share Purchase Plan July 28, 2025 Questcorp Mining Engages Contractor for Commencement of North... February 3, 2026 Prismo Metals Identifies Porphyry Style Mineralization at Silver... September 15, 2025 CDX May Investor Presentation May 30, 2025 Australia, US Pen Rare Earth Metals Deal in... October 21, 2025 White House Unveils 90 Point AI Strategy July 24, 2025 Psychedelics Market Update: H1 2025 in Review July 31, 2025 Silver Hammer Closes CDN$1,809,000 Fully Subscribed Non-Brokered Private... September 19, 2025 Harvest Gold Identifies 15 Primary And 10 Secondary... June 13, 2025 Group Eleven Announces C$5M Bought Deal Private Placement July 22, 2025